New developments

Opinion

... in response to Link between MRI contrast agent and nephrogenic systemic fibrosis

New developments

laurie says:

December 10, 2009 at 8:57 AM

An FDA panel says new warning labels are needed for Omniscan and Optimark gadolinium contrast dyes because their risk of NSF is greatest.

Reply »

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.